EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cellular Signalling

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CELLSIG.2009.01.034PMID 19385051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes.

  2008cited by this paper
• Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.

  2007cited by this paper
• Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metal loproteinase Induction

  2007cited by this paper
• The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases

  2007cited by this paper
• SFK–STAT Pathway: An Alternative and Important Way to Malignancies

  2006cited by this paper
• JAK/STAT-dependent gene regulation by cytokines.

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• Gelatinase-mediated migration and invasion of cancer cells.

  2005cited by this paper
• EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.

  2004cited by this paper
• Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines

  2003cited by this paper
• Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

  2003cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Stat proteins and oncogenesis.

  2002cited by this paper
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

  2002cited by this paper
• Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.

  2001cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• Constitutive activation of JAK–STAT3 signaling by BRCA1 in human prostate cancer cells

  2001cited by this paper
• Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

  2000cited by this paper
• The EGF receptor family as targets for cancer therapy

  2000cited by this paper
• Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.

  2000cited by this paper
• Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

  1999cited by this paper
• Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.

  1998cited by this paper
• Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion

  1998cited by this paper
• Changing views of the role of matrix metalloproteinases in metastasis.

  1997cited by this paper
• Growth factor-dependent phosphoinositide signalling.

  1997cited by this paper
• Epidermal growth factor and amphiregulin up‐regulate matrix metalloproteinase‐9 (MMP‐9) in human breast cancer cells

  1997cited by this paper
• In vitro activation of Stat3 by epidermal growth factor receptor kinase.

  1996cited by this paper
• Transcriptional regulation by extracellular signals: mechanisms and specificity.

  1995cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• Protein modules and signalling networks

  1995cited by this paper
• Regions of the JAK2 Tyrosine Kinase Required for Coupling to the Growth Hormone Receptor (*)

  1995cited by this paper
• Jaks and Stats in signaling by the cytokine receptor superfamily.

  1995cited by this paper
• The epidermal growth factor.

  1995cited by this paper
• Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.

  1993cited by this paper
• EGF receptor in neoplasia and metastasis

  1993cited by this paper
• Co‐expression of the genes encoding transforming growth factor‐α and its receptor in papillary carcinomas of the thyroid

  1990cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper
• Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

  1987cited by this paper

• STAT3 axis in cancer and cancer stem cells: From oncogenesis to targeted therapies.

  2025cites this paper
• Coralyne Targets the Catalytic Domain of MMP9: An In Silico and In Vitro Investigation.

  2025cites this paper
• Multiple anti-tumor programs are activated by blocking BAD phosphorylation

  2025cites this paper
• Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer.

  2025cites this paper
• Methoxylated Flavones from Casimiroa edulis La Llave Suppress MMP9 Expression via Inhibition of the JAK/STAT3 Pathway and TNFα-Dependent Pathways.

  2024cites this paper
• Application of Pro-angiogenic Biomaterials in Myocardial Infarction

  2024cites this paper
• Serum Starvation Induces Matrix Metalloproteinase 9 Expression in Nasopharyngeal Carcinoma Cells Through the ERK-AP1 Pathway In Vitro

  2023cites this paper
• Evaluation of coumarin and their derivatives as Janus Kinase-3 inhibitors using a theoretical model

  2023cites this paper
• Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma.

  2021cites this paper
• Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors

  2020cites this paper
• The downregulation of microRNA-375 in human cervical squamous cell carcinoma promotes invasion and migration by targeting JAK2

  2020cites this paper
• Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases

  2020cites this paper
• Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.

  2019cites this paper
• EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling

  2019cites this paper
• Leptin Promotes Expression of EMT-Related Transcription Factors and Invasion in a Src and FAK-Dependent Pathway in MCF10A Mammary Epithelial Cells

  2019cites this paper
• Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets

  2019cites this paper
• The effect of Matrigel concentrations and Cannabidiol on metastatic breast cancer cells and noncancerous fibroblasts

  2019cites this paper
• UNC5C-knockdown enhances the growth and metastasis of breast cancer cells by potentiating the integrin α6/β4 signaling pathway

  2019cites this paper
• Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition via Down-regulation of EGFR Pathway in MDA-MB-231 cells.

  2018cites this paper
• Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells

  2018cites this paper
• COLLAGENS TYPES I AND II IN BREAST TUMORS

  2018cites this paper
• Inhibiting pulmonary metastasis of breast cancer based on dual-targeting graphene oxide with high stability and drug loading capacity.

  2018cites this paper
• Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.

  2017cites this paper
• Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.

  2017cites this paper
• NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?

  2017cites this paper
• Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK/AP-1 signaling pathway in human breast cancer MCF-7 cells

  2017cites this paper
• A novel epidermal growth factor receptor inhibitor for treating lung cancer

  2017cites this paper
• IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules

  2017cites this paper
• Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Breast Cancer Patients

  2017cites this paper
• Calmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells

  2017cites this paper
• MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression

  2017cites this paper
• Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK.

  2016cites this paper
• Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer.

  2016cites this paper
• Epidermal growth factor (EGF) triggers the malignancy of hemangioma cells via activation of NF-κB signals.

  2016cites this paper
• Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression

  2016cites this paper
• Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.

  2016cites this paper
• Varying Effects of EGF, HGF and TGFβ on Formation of Invadopodia and Invasiveness of Melanoma Cell Lines of Different Origin

  2016cites this paper
• Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.

  2016cites this paper
• Levels of Matrix Metalloproteinases in Arthroplasty Patients and Their Correlation With Inflammatory and Thrombotic Activation Processes

  2016cites this paper
• Retraction Note to: The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma

  2015cites this paper
• ADAM15 targets MMP9 activity to promote lung cancer cell invasion.

  2015cites this paper
• Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway

  2015cites this paper
• Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells

  2015cites this paper
• Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells.

  2015cites this paper
• SEMA4B inhibits growth of non-small cell lung cancer in vitro and in vivo.

  2015cites this paper
• Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells

  2015cites this paper
• Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells

  2015cites this paper
• PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop

  2015cites this paper
• MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer

  2015cites this paper
• Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

  2015cites this paper
• Acetylcholine Inhibits LPS-Induced MMP-9 Production and Cell Migration via the a7 nAChR-JAK2/STAT3 Pathway in RAW264.7 Cells

  2015cites this paper
• Aldosterone up-regulates MMP-9 and MMP-9/NGAL expression in human neutrophils through p38, ERK1/2 and PI3K pathways.

  2015cites this paper
• Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancer

  2015cites this paper
• CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways

  2014cites this paper
• Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B.

  2014cites this paper
• Tie2 Signaling Cooperates with TNF to Promote the Pro-Inflammatory Activation of Human Macrophages Independently of Macrophage Functional Phenotype

  2014cites this paper
• RETRACTED ARTICLE: MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer

  2014cites this paper
• RETRACTED ARTICLE: MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma

  2014cites this paper
• Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines

  2014cites this paper
• Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells.

  2014cites this paper
• MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer

  2014cites this paper
• Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.

  2014cites this paper
• RETRACTED ARTICLE: The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma

  2014cites this paper
• Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin.

  2014cites this paper
• RETRACTED ARTICLE: Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13

  2014cites this paper
• MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A

  2014cites this paper
• RETRACTED ARTICLE: Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma

  2014cites this paper
• RETRACTED ARTICLE: Inhibition of FoxO1 nuclear exclusion prevents metastasis of Glioblastoma

  2014cites this paper
• Bioaerosols from a Food Waste Composting Plant Affect Human Airway Epithelial Cell Remodeling Genes

  2013cites this paper
• Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.

  2013cites this paper
• Tetraspanin CD9: Contributions to Cancer Cell and Vascular Cell Phenotypes from the Sixth Man

  2013cites this paper
• Major Signaling Pathways Involved in Breast Cancer

  2013cites this paper
• Pro-MMP-9 upregulation in HT1080 cells expressing CD9 is regulated by epidermal growth factor receptor.

  2013cites this paper
• Oncogenic K-Ras and Loss of Smad4 Mediate Invasion by Activating an EGFR/NF-κB Axis That Induces Expression of MMP9 and uPA in Human Pancreas Progenitor Cells

  2013cites this paper
• Acción del hexaclorobenceno en la migración, invasión y metástasis en modelos experimentales de cáncer de mama

  2012cites this paper
• Activating Transcription Factor 3 and the Nervous System

  2012cites this paper
• Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells.

  2012cites this paper
• Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.

  2012cites this paper
• A functional comparison between the HER2high/HER3 and the HER2low/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells

  2012cites this paper
• MODULATION OF APOPTOSIS IN HUMAN URETHRAL EPITHELIAL CELLS BY WILD-TYPE NEISSERIA GONORRHOEAE AND ITS ISOGENIC MinD MUTANT STRAIN

  2012cites this paper
• Differential Effect of Growth Factors on Invasion and Proliferation of Endocrine Resistant Breast Cancer Cells

  2012cites this paper
• Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.

  2012cites this paper
• Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.

  2011cites this paper
• ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells.

  2011cites this paper
• Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells

  2010cites this paper
• Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells.

  2010cites this paper
• Induction of tissue inhibitor of matrix metalloproteinase-2 by cholesterol depletion leads to the conversion of proMMP-2 into active MMP-2 in human dermal fibroblasts

  2010cites this paper
• Molecular basis of anti‐inflammatory action of platelet‐rich plasma on human chondrocytes: Mechanisms of NF‐κB inhibition via HGF

  2010cites this paper
• Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells

  2010cites this paper
• TNF‐α induces matrix metalloproteinase‐9 expression in A549 cells: Role of TNFR1/TRAF2/PKCα‐dependent signaling pathways

  2010cites this paper
• Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

  2010cites this paper
• DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes.

  2010cites this paper
• An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.

  2010cites this paper
• Epidermal growth factor receptor (EGFR)-inhibitors, rashes, and survival: is doxycycline the missing link?

  2010cites this paper
• Conception, synthèse et évaluation pharmacologique de nouveaux dérivés quinazoliniques à activité anticancéreuse potentielle

  2009cites this paper
• Current world literature.

  2005cites this paper
• ADAM 15 targets MMP 9 activity to promote lung cancer cell invasion

  year unknowncites this paper